StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$46.38−1.63 (-3.40%)

Close on Nov 19, 2026Market cap $1.38BP/E 19.2Yield 1.29%

Conmed net income

Net income is the profit left for shareholders after every expense, interest and tax.

Conmed's net income for the twelve months ending Sep 30, 2026 was $73.43M, up 14.6% year over year. For fiscal 2025 it was $47.06M, down 64.5% from the year before. Over ten years it grew 4.4% a year on average. The highest annual figure on record is $132.42M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$47.06M-64.5%
FY2024Dec 31, 2024$132.42M+105.4%
FY2023Dec 31, 2023$64.46M–
FY2022Dec 31, 2022-$80.58M-228.8%
FY2021Dec 31, 2021$62.54M+557.2%
FY2020Dec 31, 2020$9.52M-66.7%
FY2019Dec 31, 2019$28.62M-29.9%
FY2018Dec 31, 2018$40.85M-26.4%
FY2017Dec 31, 2017$55.49M+278.4%
FY2016Dec 31, 2016$14.66M-51.9%
FY2015Dec 31, 2015$30.50M-5.3%
FY2014Dec 31, 2014$32.19M-10.4%
FY2013Dec 31, 2013$35.94M-11.2%
FY2012Dec 31, 2012$40.48M+5283.1%
FY2011Dec 31, 2011$752.00K-97.5%
FY2010Dec 31, 2010$30.35M+150.0%
FY2009Dec 31, 2009$12.14M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$19.80M+592.4%
Q2 FY2026Jun 30, 2026$23.07M+7.7%
Q1 FY2026Mar 31, 2026$13.83M+129.1%
Q4 FY2025Dec 31, 2025$16.74M-50.4%
Q3 FY2025Sep 30, 2025$2.86M-94.2%
Q2 FY2025Jun 30, 2025$21.42M-28.5%
Q1 FY2025Mar 31, 2025$6.04M-69.4%
Q4 FY2024Dec 31, 2024$33.76M+2.1%
Q3 FY2024Sep 30, 2024$48.98M+209.3%
Q2 FY2024Jun 30, 2024$29.98M+118.3%
Q1 FY2024Mar 31, 2024$19.71M+983.5%
Q4 FY2023Dec 31, 2023$33.07M+24.4%
Q3 FY2023Sep 30, 2023$15.84M-65.7%
Q2 FY2023Jun 30, 2023$13.73M–
Q1 FY2023Mar 31, 2023$1.82M-87.9%
Q4 FY2022Dec 31, 2022$26.58M+8.8%
Q3 FY2022Sep 30, 2022$46.15M+208.7%
Q2 FY2022Jun 30, 2022-$168.29M-1366.3%
Q1 FY2022Mar 31, 2022$14.98M+51.9%
Q4 FY2021Dec 31, 2021$24.44M+1.3%
Q3 FY2021Sep 30, 2021$14.95M+118.2%
Q2 FY2021Jun 30, 2021$13.29M–
Q1 FY2021Mar 31, 2021$9.86M+66.4%
Q4 FY2020Dec 31, 2020$24.14M+61.7%
Q3 FY2020Sep 30, 2020$6.85M-1.7%
Q2 FY2020Jun 30, 2020-$27.40M-581.1%
Q1 FY2020Mar 31, 2020$5.93M+480.5%
Q4 FY2019Dec 31, 2019$14.93M-4.6%
Q3 FY2019Sep 30, 2019$6.97M+19.7%
Q2 FY2019Jun 30, 2019$5.70M-34.7%
Q1 FY2019Mar 31, 2019$1.02M-90.4%
Q4 FY2018Dec 31, 2018$15.65M-66.5%
Q3 FY2018Sep 30, 2018$5.83M-19.1%
Q2 FY2018Jun 30, 2018$8.72M+42.0%
Q1 FY2018Mar 31, 2018$10.66M–
Q4 FY2017Dec 31, 2017$46.70M+596.1%
Q3 FY2017Sep 30, 2017$7.20M–
Q2 FY2017Jun 30, 2017$6.14M–
Q1 FY2017Mar 31, 2017-$4.55M–
Q4 FY2016Dec 31, 2016$6.71M–

More Conmed figures

See a number that looks wrong?